Actively Recruiting
PGHD-AI Intelligent Model for the Nutritional Assessment and Intervention of Patients After Radical Surgery for Pancreatic Cancer.
Led by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Updated on 2025-09-11
200
Participants Needed
1
Research Sites
45 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will collect patient PRO (physical strength, pain, defecation, appetite, weight, etc.) data through the APP, use corpus collection cards, facial photography and other technologies to collect PGHD characteristic phenotypes, and then combine artificial intelligence technology to train and cultivate agents (agents) to carry out joint offline routine follow-up of patients after radical pancreatic cancer resection to evaluate the feasibility of nutritional risk assessment intervention. Thus, the feasibility of artificial intelligence prediction of health status is verified, and an efficient follow-up tool and nutritional support evaluation plan are provided for the management of pancreatic cancer patients throughout the course of the disease, so as to improve the treatment prognosis and quality of life of pancreatic cancer patients.
CONDITIONS
Official Title
PGHD-AI Intelligent Model for the Nutritional Assessment and Intervention of Patients After Radical Surgery for Pancreatic Cancer.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years and voluntarily signed informed consent
- Clinical and pathological diagnosis of pancreatic cancer (ICD-10:C25)
- Fully recovered from radical pancreatic cancer surgery at randomization
- ECOG performance status score of 0-1
- Able to complete follow-up and examinations during the study
You will not qualify if you...
- Patients or their families are unwilling to use the APP
- Current or past history of metastatic or locally recurrent pancreatic cancer
- Serious organ dysfunctions such as severe liver or kidney failure, or heart failure
- Women who are pregnant or breastfeeding
- History of other tumors
- Any other conditions that make participation unsafe or unsuitable, including serious medical conditions, safety risks, or issues affecting study compliance
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai General Hospital
Shanghai, Shanghai Municipality, China, 200080
Actively Recruiting
Research Team
L
Long Jiang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here